BioNJ 2023 BioPartnering Conference

We are proud to sponsor BioNJ’s 2023 BioPartnering Conference and are pleased to announce that partners Alan Leeds and David Schwartz will present on key topics, including leveraging capital and best practices in biotech.

Opening remarks will be provided by partner Steve Cohen, who will discuss the importance of fostering productive collaborations and partnerships, facilitating investment opportunities, and bolstering medical innovation.

Partnering & Raising Capital – Best Practices in Recovering Biotech Sector
Partner Alan Leeds, Presenter
9:30–10:10 am ET

• This panel will explore balancing the need to raise capital for medium-term pipeline gaps before a potential reset of biotech valuations, including potential advantages of M&A, partnering with large pharma, and better biotech/investor focus.

Navigating the Journey From Start-Up to Commercialization: Avoiding “Oh No!” Moments
Partner David Schwartz, Presenter
1:05–1:45 pm ET

• This panel will explore opportunities to stretch precious capital raised for infrastructure, banking, compliance, and reporting developments while maintaining appropriate controls, compliance, and reporting to support growth from start-up to commercialization.